RAPT (rapt.com) Bozor qiymatining balans qiymatiga nisbati
RAPT Therapeutics, Inc. (RAPT) rahbariyati tadqiqotlar to'xtatilganidan so'ng hozirda o'z strategiyasini qayta ko'rib chiqmoqda, bu esa bozor ishonchini o'rtacha darajada saqlab qolmoqda. Biznes onkologiya va allergiya davolash vositalarini ishlab chiqishga tayanadi, bu esa barqaror talabni ta'minlaydi. Ushbu kunlik narx harakati 6.50 qiymatini aks ettiradi. Ishlab chiqish jarayonlarini ikkita alohida tibbiy sohaga diversifikatsiya qilish orqali risklar minimallashtirilgan bo'lib, bu kompaniyani klinik sinovlarning potentsial muvaffaqiyatsizliklaridan himoya qiladi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_RAPT_-_RAPT-Therapeutics-Inc._-_Market-Capitalization-to-Net-Assets "RAPT rapt.com Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 14.03.2026) | 👁️GURU.Markets👁️")
RAPT Therapeutics Inc. (RAPT) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati RAPT Therapeutics, Inc.|RAPT - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati RAPT Therapeutics, Inc.|RAPT - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar RAPT|RAPT - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari RAPT Therapeutics
Kompaniyaning dastlabki tahlili:RAPT Therapeutics - RAPT
Fundamental jihatdan barqaror aktivlarni aniqlash uchun investorlar bozor qiymatini sof aktivlar bilan solishtirgan holda aktivlar sifatini tahlil qiladilar. Ushbu bokiy qiymat nisbati kapital mukofotini aks ettiradi, u RAPT Therapeutics, Inc. (RAPT) uchun bevosita klinik sinovlarning muvaffaqiyati va tartibga soluvchi cheklovlarning olib tashlanishiga bog'liq bo'lib, shu orqali kelgusidagi R&D yutuqlarining adolatli bahosini belgilaydi.
Asosiy raqobatchilar
ARGX - Kapitallashuvning sof aktivlarga nisbati|BNTX (biontech.de) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Savara Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Rigel Pharmaceuticals Inc (RIGL)|ANAB - Balans qiymatiga nisbatan bozor qiymati|ATXS: Bozor kapitallashuvining balans qiymatiga nisbati|ENGN (engene.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Aerovate Therapeutics, Inc. JBIO|Sof aktivlarga nisbatan bozor kapitallashuvi Aclaris Therapeutics Inc. (ACRS)|Kapitallashuvning sof aktivlarga nisbati Kyverna|Bozor kapitallashuvining balans qiymatiga multiplikatori Tiziana Life Sciences, Ltd. TLSA|Kapitallashuvning sof aktivlarga nisbati Cabaletta Bio, Inc.|VTYX - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati Theratechnologies THTX|AVTX - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati Eledon ELDN|Agenus, Inc (AGEN) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CLYM (Climb Bio Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti ZURA|aTyr Pharma (ATYR) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati adagene.com (ADAG)|Bozor kapitallashuvining balans qiymatiga nisbati IMA (Ikena Oncology)|Shattuck Labs Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Equillium Bio|CNTB - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati IMUX|Bozor qiymatining balans qiymatiga koeffitsiyenti Atara Bio|IFRX (InflaRx NV) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati X4 Pharmaceuticals, Inc (XFOR)|Kapitallashuvning sof aktivlarga nisbati Adicet Bio|Bozor kapitallashuvining balans qiymatiga multiplikatori celularity.com (CELU)|Bozor kapitallashuvining balans qiymatiga nisbati INMB|Balans qiymatiga nisbatan bozor kapitallashuvi Barinthus Biotherapeutics PLC BRNS|KZR: Bozor kapitallashuvining balans qiymatiga nisbati|SABS: Kapitallashuvning sof aktivlarga nisbati|Akari Therapeutics - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Enlivex Therapeutics Ltd.|QTTB - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati GeoVax Labs|EDSA (Edesa) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IBIO (iBio Corporation)|CARM - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati xtlbio.com XTLB|BOLT: Bozor kapitallashuvining balans qiymatiga nisbati|HCW Biologics Inc. (HCWB) - Kapitallashuvning sof aktivlarga nisbati|aptevotherapeutics.com - Kapitallashuvning sof aktivlarga nisbati|AIM (aimimmuno.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|ADTX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati gribio.com|Bozor kapitallashuvining balans qiymatiga nisbati XRTX|Bozor kapitallashuvining balans qiymatiga nisbati HIND (Vyome Holdings Inc.)|Revelation Bio (REVB) - Bozor qiymatining balans qiymatiga nisbati|INDP - Sof aktivlarga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Scinai Immunotherapeutics SCNI|CALI: Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati affimed.com (AFMD)|Allakos (ALLK) - Sof aktivlarga nisbatan bozor kapitallashuvi|HOOK - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IGM Bio|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati OCEA (oceanbiomedical.com)|Bozor qiymatining balans qiymatiga nisbati TC BioPharm|Third Harmonic Bio Inc. - Balans qiymatiga nisbatan bozor qiymati